AI-generated analysis. Always verify with the original filing.
Barinthus Biotherapeutics plc filed a Form 8-K on March 13, 2026, furnishing Items 2.02, 7.01, and 9.01 with Exhibits 99.1 (Press Release) and 99.2 (Corporate Deck). Item 2.02 and Item 7.01 disclosures are not deemed 'filed' under Section 18 of the Exchange Act.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchan
of this Current Report on Form 8-K (including Exhibit 99.2) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, o
. Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release dated March 13 , 202 6 . 99.2 Corporate Deck dated March 2026. 104 Cover Page Interactive D